Guangzhou Kingmed Diagnostics Group Co., Ltd. (603882.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 27.50

From 52W high−19.71%

Volume15.69M

Market capCNY 13.77B

P/E (TTM)−79.5x

P/S (TTM)2.2x

Div yield3.14%

Key dataSep 18, 2026

Open

CNY 27.50

From 52W high

−19.71%

Volume

15.69M

Market cap

CNY 13.77B

ValuationView details →

P/E (Fwd)

28.4x

EV/EBITDA

40.2x

P/E (TTM)

−79.5x

RSI (14)

54.3

MomentumView details →

1D Return

−5.17%

YTD Return

−1.23%

ValuationView details →

P/E (Fwd)

28.4x

P/E (TTM)

−79.5x

EV/EBITDA

40.2x

EV/Sales

1.9x

P/S (TTM)

2.2x

P/B (TTM)

2.2x

ProfitabilityView details →

Gross Margin

35.15%

Net Margin

−1.74%

EBITDA Margin

4.83%

ROE (TTM)

−1.62%

ROA (TTM)

−1.12%

Asset Turnover

0.63x

GrowthView details →

Revenue YoY

−13.20%

EPS YoY

+73.93%

FCF YoY

+19.03%

Revenue CAGR 3Y

−26.96%

EPS CAGR 3Y

+54.88%

EBITDA YoY

—

MomentumView details →

1D Return

−5.17%

YTD Return

−1.23%

1Y Return

−8.73%

RSI (14)

54.3

vs 50D SMA

+0.74%

vs 200D SMA

+0.44%

Capital & dividendView details →

Debt/Equity

0.11x

Current Ratio

3.13x

Quick Ratio

3.04x

Div Yield

3.14%

Div Rate

CNY 0.88

Div Growth 1Y

+0.00%

EarningsView details →

EPS (Actual)

CNY 0.33

EPS Surprise

1.52%

Beats (12Q)

1/12

Next Q EPS Est

CNY 0.26

Avg Surprise (4Q)

1.52%

Rev Surprise

−11.61%

Financials snapshotView financials →

Revenue (TTM)

5.91B

Net Income (TTM)

−102.67M

Op. CF (TTM)

1.19B

Next earningsOct 23, 2026 →

Latest newsMore news →

KingMed Diagnostics established a new wholly-owned subsidiary, Guangzhou Jinkun Medical Laboratory Co., Ltd., with registered capital of 10 million yuan, to engage in medical services and related businesses.18d ago

KingMed Diagnostics announced its 2026 first-half results: net profit attributable to shareholders was 190 million yuan, turning from a loss in the same period last year.27d ago

Similar companies

Charles River Laboratories International, Inc.CRL ICON Public Limited CompanyICLR Revvity, Inc.RVTY Medpace Holdings, Inc.MEDP Twist Bioscience CorporationTWST Joinn Laboratories(China)Co.,Ltd.06127.HK Find similar companies →

Latest newsMore news →

KingMed Diagnostics established a new wholly-owned subsidiary, Guangzhou Jinkun Medical Laboratory Co., Ltd., with registered capital of 10 million yuan, to engage in medical services and related businesses.18d ago KingMed Diagnostics announced its 2026 first-half results: net profit attributable to shareholders was 190 million yuan, turning from a loss in the same period last year.27d ago